News

The study has demonstrated that VRX1023 is capable of achieving control of viral load over the course of four months following a challenge with a pathogenic simian immunodeficiency

Zyto’s SMP program teams Zyto with nutriceutical suppliers who serve healthcare professionals exclusively. Vaughn Cook, CEO of Zyto, said: “The SMP program is a joint effort between Zyto

Earlier, in October 2009, the division of reproductive and urologic products at FDA has issued a complete response letter for the biologic license application (BLA) for Prolia in

The instrument removes a key bottleneck in the current workflow for sequencing by replacing the tedious gel isolation and purification steps used for size selection of sheared genomic

The Acquisition was finalised after the approval by Asterand’s shareholders at an extraordinary general meeting held on February 18, 2010, where all resolutions put to shareholders were duly

Loprox (Ciclopirox Shampoo, 1%) is an antifungal indicated for the treatment of seborrheic dermatitis of the scalp in adults. According to Wolters Kluwer data, estimated annual brand sales

ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, US-registration trial designed to demonstrate the effectiveness of HPV detection as part of a cervical cancer screening program. The Roche ATHENA

The agreements are expected to expand the application of Codexis’ technology to a broadened pipeline of branded innovator pharmaceutical products. As per the new agreements, Codexis will apply

GDC-0449 was discovered by Genentech, under the ongoing collaboration agreement between Genentech and Curis, and was jointly validated through a series of preclinical studies. Through this partnership, the